Newsvine - business - Wire
Stocks that were moving substantially or trading heavily Monday on the New York Stock Exchange and Nasdaq Stock Market:
Latest financial news - CNNMoney.com
BusinessWeek Online -- Investing
Analyst opinions on stocks making headlines Monday
Newsvine - business - Wire
A patent dispute over the heartburn drug Protonix escalated Monday when Wyeth said it will sue to recover lost profits from sales of Teva Pharmaceutical Industries Ltd.'s generic version.
Yahoo! News: Business
Reuters - Israel's Teva Pharmaceutical Industries Ltd raised its 2007 earnings outlook following the launch of its generic version of Wyeth's ulcer drug Protonix.
Reuters: Business News
TEL AVIV (Reuters) - Israel's Teva Pharmaceutical Industries Ltd raised its 2007 earnings outlook following the launch of its generic version of Wyeth's ulcer drug Protonix.
MarketWatch.com - Top Stories
TEL AVIV (MarketWatch) -- Teva Pharmaceutical Industries Ltd. lifted its 2007 earnings estimate Monday as the generic drugmaker launched a version of the Protonix acid-reflux treatment.
WSJ.com: What's News US
Teva raised its full-year outlook after announcing its launch of generic equivalents to Wyeth's Protonix, an acid-reflux treatment. Wyeth said it will pursue a patent-infringement claim for lost profits and other damages.
BusinessWeek Online -- Investing
Plus more stocks making headlines in Monday's market